Skip to Content

Industry Insights.

Search By Author:
4 / 7 / 2025

Early Involvement of Regulatory and Quality of Systems Expertise in Financial Transactions

By
Christine Scifert &
Dawn Norman &
David White &
Drew Hoffman
Introduction and Value Managing risk and uncertainty in the world of investment is a critical advantage. Investing in the medical device industry offers tremendous potential for returns, driven by constant...
5 / 23 / 2024

Compliant Speaker Programs: How Life Sciences Companies Can Mitigate Risk

By
Ann Brandt
Pharmaceutical, medical device, and biotechnology companies (collectively life sciences companies or “LSCs”) utilize outside ‘experts’ (“Healthcare Professionals” and “Key Opinion Leaders”, collectively “HCPs/KOLs”) to provide a wide variety of...
10 / 10 / 2023

Determining the Fair Market Value of HCP Compensation: Five Considerations When Engaging Speakers, Consultants, and Researchers Outside the U.S.

By
Ann Brandt
In many countries and regions of the world, access to valid, reliable, and comprehensive healthcare professional (“HCP”) compensation data can be a challenging task. Notwithstanding, in countries outside of...